ArticleJournal of clinical medicine2025

Effectiveness of a 5-Hydroxytryptamine Type 3 Receptor Antagonist for Treating Nintedanib-Induced Diarrhea: A Prospective Observational Study.

Toru Arai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.